If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

ABCL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 30.30%

Insider Buying (Last 12 Months): $14,865,015.03

Insider Selling (Last 12 Months): $0.00

AbCellera Biologics Insider Trading History Chart

AbCellera Biologics Share Price & Price History

^$7.62

▲ +0.05 (0.66%)

As of 03/21/2023 05:00 PM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

AbCellera Biologics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/16/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	85,102	$10.10	$859,530.20	55,859,493
8/19/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	200,000	$11.46	$2,292,000.00	55,844,391
6/13/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	54,915	$8.03	$440,967.45	55,635,218
6/6/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	64,545	$7.50	$484,087.50	55,580,303
5/16/2022	Veronique Lecault	COO	Buy	200,000	$6.34	$1,268,000.00	1,770,122
5/12/2022	Andrew Booth	CFO	Buy	85,000	$5.79	$492,150.00	138,500
5/12/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	1,408,468	$6.41	$9,028,279.88	55,215,758
3/4/2022	John S. Montalbano	Director	Buy	10,000	$8.54	$85,400.00
3/1/2022	John S. Montalbano	Director	Buy	20,000	$9.05	$181,000.00
2/28/2022	Veronique Lecault	COO	Buy	230,789	$8.66	$1,998,632.74
12/3/2021	Andrew Lo	Director	Buy	86,938	$14.02	$1,218,870.76
11/11/2021	Andrew Booth	CFO	Buy	53,500	$14.74	$788,590.00
11/11/2021	Holdings Ltd. Thermopylae	Major Shareholder	Buy	202,960	$14.76	$2,995,689.60
8/31/2021	John Hamer	Director	Sell	162,649	$16.95	$2,756,900.55
8/16/2021	John S. Montalbano	Director	Buy	6,000	$17.23	$103,380.00
6/22/2021	Michael R. Hayden	Director	Sell	100,000	$25.50	$2,550,000.00
6/9/2021	Andrew Booth	CFO	Sell	1,200,000	$25.50	$30,600,000.00
6/9/2021	Carl L. G. Hansen	CEO	Sell	6,000,000	$24.13	$144,780,000.00
6/9/2021	Holdings Ltd. Thermopylae	Major Shareholder	Sell	5,598,420	$24.03	$134,530,032.60	55,604,330
6/9/2021	Veronique Lecault	COO	Sell	1,000,000	$25.50	$25,500,000.00	1,006,000

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for AbCellera Biologics (NASDAQ:ABCL)

42.19% of AbCellera Biologics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

AbCellera Biologics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/28/2023	Voya Investment Management LLC	11,014,862	$111.58M	0.2%	+2.2%	3.829%
2/21/2023	Macquarie Group Ltd.	119,399	$1.21M	0.0%	N/A	0.042%
2/17/2023	Truist Financial Corp	51,543	$0.52M	0.0%	N/A	0.018%
2/16/2023	Point72 Middle East FZE	15,031	$0.15M	0.0%	N/A	0.005%
2/16/2023	State of Wyoming	12,906	$0.13M	0.0%	+33.9%	0.005%
2/15/2023	MetLife Investment Management LLC	109,657	$1.11M	0.0%	-2.7%	0.038%
2/15/2023	Lazard Asset Management LLC	2,906,212	$29.44M	0.0%	-11.5%	1.016%
2/15/2023	Bridgefront Capital LLC	13,770	$0.14M	0.1%	N/A	0.005%
2/15/2023	Virtu Financial LLC	32,598	$0.33M	0.0%	+116.6%	0.011%
2/15/2023	Stansberry Asset Management LLC	100,176	$1.02M	0.2%	+2.1%	0.035%
2/15/2023	Susquehanna Fundamental Investments LLC	203,675	$2.06M	0.0%	-40.8%	0.071%
2/15/2023	Schonfeld Strategic Advisors LLC	154,800	$1.57M	0.0%	-30.5%	0.054%
2/15/2023	Squarepoint Ops LLC	197,572	$2M	0.0%	+304.9%	0.069%
2/15/2023	Mackenzie Financial Corp	14,212	$0.14M	0.0%	-17.3%	0.005%
2/15/2023	Maverick Capital Ltd.	27,637	$0.28M	0.0%	+23.1%	0.010%
2/15/2023	Morgan Stanley	635,534	$6.44M	0.0%	-9.6%	0.222%
2/15/2023	Man Group plc	305,478	$3.09M	0.0%	-54.1%	0.107%
2/15/2023	Norges Bank	646,699	$6.55M	0.0%	N/A	0.226%
2/15/2023	Delphia USA Inc.	18,282	$0.19M	0.2%	-14.0%	0.006%
2/15/2023	Algert Global LLC	48,480	$0.49M	0.0%	N/A	0.017%
2/15/2023	AQR Capital Management LLC	32,913	$0.33M	0.0%	N/A	0.012%
2/14/2023	Alyeska Investment Group L.P.	100,000	$1.01M	0.0%	N/A	0.035%
2/14/2023	Price T Rowe Associates Inc. MD	35,963	$0.36M	0.0%	+6.7%	0.013%
2/14/2023	Guardian Capital Advisors LP	1,786,414	$18.22M	2.1%	-52.2%	0.624%
2/14/2023	Cetera Advisors LLC	13,648	$0.14M	0.0%	N/A	0.005%
2/14/2023	Amundi	16,777	$0.16M	0.0%	-29.7%	0.006%
2/14/2023	Marshall Wace LLP	97,600	$0.99M	0.0%	-72.5%	0.034%
2/14/2023	Two Sigma Investments LP	960,712	$9.73M	0.0%	-20.0%	0.336%
2/14/2023	Engineers Gate Manager LP	74,105	$0.75M	0.0%	-5.3%	0.026%
2/13/2023	Gyon Technologies Capital Management LP	25,818	$0.26M	0.1%	N/A	0.009%
2/13/2023	Charles Schwab Investment Management Inc.	466,027	$4.72M	0.0%	+2.0%	0.163%
2/13/2023	Deutsche Bank AG	218,620	$2.22M	0.0%	+12.9%	0.076%
2/13/2023	Wells Fargo & Company MN	84,330	$0.85M	0.0%	+9.7%	0.029%
2/13/2023	Barclays PLC	317,028	$3.21M	0.0%	+34.1%	0.111%
2/13/2023	Renaissance Technologies LLC	2,122,403	$21.50M	0.0%	-28.8%	0.742%
2/13/2023	ExodusPoint Capital Management LP	180,350	$1.83M	0.0%	+3.2%	0.063%
2/13/2023	Martingale Asset Management L P	121,867	$1.24M	0.0%	+145.4%	0.043%
2/13/2023	Geode Capital Management LLC	2,067,513	$20.94M	0.0%	+4.1%	0.723%
2/13/2023	American Century Companies Inc.	1,288,257	$13.05M	0.0%	+123.9%	0.450%
2/13/2023	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	250,248	$2.54M	0.0%	N/A	0.087%
2/13/2023	GSA Capital Partners LLP	111,894	$1.13M	0.1%	N/A	0.039%
2/13/2023	Advisory Research Inc.	39,843	$0.40M	0.0%	-48.7%	0.014%
2/13/2023	Capital Fund Management S.A.	185,968	$1.88M	0.0%	+514.2%	0.065%
2/13/2023	JPMorgan Chase & Co.	593,184	$6.01M	0.0%	+18.6%	0.207%
2/10/2023	Bank of America Corp DE	97,429	$0.99M	0.0%	+27.6%	0.034%
2/10/2023	Gruss & Co. LLC	255,400	$2.59M	16.0%	-17.2%	0.089%
2/10/2023	Sei Investments Co.	31,640	$0.32M	0.0%	N/A	0.011%
2/10/2023	Banque Cantonale Vaudoise	33,076	$0.34M	0.0%	-24.8%	0.012%
2/10/2023	Victory Capital Management Inc.	13,444	$0.14M	0.0%	N/A	0.005%
2/10/2023	Advisor Group Holdings Inc.	74,666	$0.76M	0.0%	+6.9%	0.026%
2/10/2023	abrdn plc	284,263	$2.88M	0.0%	+3.2%	0.099%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	98,694	$1M	0.0%	+6.3%	0.034%
2/9/2023	First Trust Advisors LP	80,628	$0.82M	0.0%	N/A	0.028%
2/9/2023	Victory Capital Management Inc.	13,444	$0.14M	0.0%	N/A	0.005%
2/9/2023	Dimensional Fund Advisors LP	86,668	$0.88M	0.0%	+5.6%	0.030%
2/9/2023	Principal Financial Group Inc.	49,031	$0.50M	0.0%	+95.1%	0.017%
2/9/2023	Citigroup Inc.	7,669	$78K	0.0%	-23.9%	0.003%
2/8/2023	Raymond James & Associates	20,389	$0.21M	0.0%	-9.2%	0.007%
2/8/2023	Belpointe Asset Management LLC	3,404	$34K	0.0%	N/A	0.001%
2/8/2023	Cambridge Investment Research Advisors Inc.	43,218	$0.44M	0.0%	-4.3%	0.015%
2/8/2023	Russell Investments Group Ltd.	8,900	$90K	0.0%	+67.9%	0.003%
2/7/2023	State Board of Administration of Florida Retirement System	52,800	$0.54M	0.0%	+2.8%	0.018%
2/7/2023	Commonwealth Equity Services LLC	10,545	$0.11M	0.0%	-19.8%	0.004%
2/7/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	12,991	$0.12M	0.0%	-40.6%	0.005%
2/6/2023	Jackson Creek Investment Advisors LLC	79,168	$0.80M	0.4%	-5.3%	0.028%
2/2/2023	Intellectus Partners LLC	868,583	$8.80M	3.1%	-20.4%	0.304%
2/2/2023	ProShare Advisors LLC	50,309	$0.51M	0.0%	+7.5%	0.018%
2/1/2023	Bank of Montreal Can	63,437	$0.64M	0.0%	-56.8%	0.022%
2/1/2023	Cedar Brook Financial Partners LLC	23,965	$0.24M	0.1%	+9.1%	0.008%
2/1/2023	Cornerstone Investment Partners LLC	17,725	$0.18M	0.0%	-6.8%	0.006%
1/30/2023	New York State Common Retirement Fund	181,403	$1.84M	0.0%	+25.0%	0.063%
1/30/2023	Sumitomo Mitsui Trust Holdings Inc.	46,889	$0.48M	0.0%	+9.5%	0.016%
1/26/2023	Strs Ohio	93,400	$0.95M	0.0%	-6.4%	0.033%
1/24/2023	Asset Management Corp IL ADV	43,500	$0.44M	0.4%	+64.2%	0.015%
1/24/2023	Baillie Gifford & Co.	19,696,735	$199.53M	0.2%	+47.5%	6.847%
1/23/2023	Allspring Global Investments Holdings LLC	114,760	$1.16M	0.0%	-1.4%	0.040%
1/19/2023	Rothschild Investment Corp IL	35,100	$0.36M	0.0%	-15.8%	0.012%
1/19/2023	Counterpoint Mutual Funds LLC	15,625	$0.16M	0.2%	N/A	0.005%
1/6/2023	Renaissance Capital LLC	8,976	$91K	0.1%	N/A	0.003%
12/8/2022	Bank of New York Mellon Corp	771,244	$7.63M	0.0%	+11.8%	0.270%
11/21/2022	California State Teachers Retirement System	81,792	$0.81M	0.0%	-14.0%	0.029%
11/16/2022	Advisory Research Inc.	77,682	$0.77M	0.1%	-2.7%	0.027%
11/16/2022	Balyasny Asset Management LLC	50,832	$0.50M	0.0%	N/A	0.018%
11/15/2022	State Street Corp	3,210,819	$31.76M	0.0%	+0.5%	1.122%
11/15/2022	Twinbeech Capital LP	326,451	$3.23M	0.1%	N/A	0.114%
11/15/2022	Two Sigma Advisers LP	467,700	$4.63M	0.0%	+888.8%	0.163%
11/15/2022	Two Sigma Investments LP	1,200,538	$11.87M	0.0%	+64.9%	0.420%
11/15/2022	Vanguard Group Inc.	878,892	$8.69M	0.0%	-1.7%	0.307%
11/15/2022	Pathstone Family Office LLC	17,950	$0.18M	0.0%	-4.0%	0.006%
11/15/2022	Price T Rowe Associates Inc. MD	33,714	$0.33M	0.0%	+70.6%	0.012%
11/15/2022	Pearl River Capital LLC	62,374	$0.62M	0.1%	+139.4%	0.022%
11/15/2022	Prosight Management LP	86,504	$0.86M	0.5%	N/A	0.030%
11/15/2022	Quantamental Technologies LLC	11,999	$0.12M	0.0%	-50.0%	0.004%
11/15/2022	Marshall Wace LLP	354,397	$3.51M	0.0%	-31.0%	0.124%
11/15/2022	Martingale Asset Management L P	49,651	$0.49M	0.0%	+84.9%	0.017%
11/15/2022	ETF Managers Group LLC	84,143	$0.83M	0.0%	-6.4%	0.029%
11/15/2022	Engineers Gate Manager LP	78,249	$0.77M	0.0%	N/A	0.027%
11/15/2022	Federated Hermes Inc.	2,104,041	$20.81M	0.1%	+21.2%	0.735%
11/15/2022	Bank of New York Mellon Corp	771,244	$7.63M	0.0%	+11.8%	0.270%
11/15/2022	Bayesian Capital Management LP	34,890	$0.35M	0.1%	+30.2%	0.012%

Data available starting January 2016

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Today's Range

Now: $7.62

$7.50

$7.75

50 Day Range

MA: $9.36

$7.39

$11.18

52 Week Range

Now: $7.62

$5.42

$14.97

Volume

1,033,698 shs

Average Volume

1,727,156 shs

Market Capitalization

$2.19 billion

P/E Ratio

15.24

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of AbCellera Biologics?: AbCellera Biologics' top insider shareholders include:
Holdings Ltd Thermopylae (Major Shareholder)
Veronique Lecault (COO)
Andrew Booth (CFO)
Andrew Lo (Director)
Carl L G Hansen (CEO)
John Hamer (Director)
John S Montalbano (Director)
Michael R Hayden (Director)
Learn More about top insider investors at AbCellera Biologics.
Who are the major institutional investors of AbCellera Biologics?: AbCellera Biologics' top institutional shareholders include:
Baillie Gifford & Co. — 6.85%
Voya Investment Management LLC — 3.83%
Lazard Asset Management LLC — 1.02%
Renaissance Technologies LLC — 0.74%
Geode Capital Management LLC — 0.72%
Guardian Capital Advisors LP — 0.62%
Learn More about top institutional investors of AbCellera Biologics stock.
Which major investors are selling AbCellera Biologics stock?: Within the last quarter, ABCL stock was sold by these institutional investors:
Guardian Capital Advisors LP
Renaissance Technologies LLC
Lazard Asset Management LLC
Man Group plc
Marshall Wace LLP
Two Sigma Investments LP
Intellectus Partners LLC
Susquehanna Fundamental Investments LLC
Which major investors are buying AbCellera Biologics stock?: In the last quarter, ABCL stock was purchased by institutional investors including:
Baillie Gifford & Co.
American Century Companies Inc.
Norges Bank
Commonwealth of Pennsylvania Public School Empls Retrmt SYS
Voya Investment Management LLC
Capital Fund Management S.A.
Squarepoint Ops LLC
Macquarie Group Ltd.
Within the previous year, these company insiders have bought AbCellera Biologics stock:
Holdings Ltd Thermopylae (Major Shareholder)
Veronique Lecault (COO)
Andrew Booth (CFO)
Andrew Lo (Director)
Carl L G Hansen (CEO)
Learn More investors buying AbCellera Biologics stock.

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

ABCL Insider Trading

AbCellera Biologics Insider Trading History Chart

AbCellera Biologics Share Price & Price History

AbCellera Biologics Insider Trading History

SEC Filings (Institutional Ownership Changes) for AbCellera Biologics (NASDAQ:ABCL)

Institutional Buying and Selling by Quarter

AbCellera Biologics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of AbCellera Biologics?

Who are the major institutional investors of AbCellera Biologics?

Which major investors are selling AbCellera Biologics stock?

Which major investors are buying AbCellera Biologics stock?